FDA Inspection 1100277 — Phil Inter Pharma USA, Inc.
The FDA completed an inspection of Phil Inter Pharma USA, Inc. on July 25, 2019 in Rancho Cucamonga, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 25, 2019
- Fiscal Year
- 2019
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Rancho Cucamonga, CA (United States)